Search Results - "Dousson, Cyril"
-
1
Is there any need for new, long-acting nucleos(t)ide analogues for the treatment of hepatitis B infection?
Published in Journal of hepatology (01-05-2021)Get full text
Journal Article -
2
Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection
Published in Antiviral chemistry & chemotherapy (01-01-2018)“…This review describes the current state of discovery of past most important nucleoside and nucleotide prodrugs in the treatment of hepatitis C virus infection…”
Get full text
Journal Article -
3
HBV replication inhibitors
Published in Antiviral research (01-07-2020)“…Chronic Hepatitis B Virus infections afflict >250 million people and kill nearly 1 million annually. Current non-curative therapies are dominated by…”
Get full text
Journal Article -
4
Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Published in Journal of medicinal chemistry (13-01-2011)“…A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed. Chemical variation in the phosphorus…”
Get full text
Journal Article -
5
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-09-2017)“…[Display omitted] Herein we describe the discovery of IDX21437 35b, a novel RPd-aminoacid-based phosphoramidate prodrug of 2′-α-chloro-2′-β-C-methyluridine…”
Get full text
Journal Article -
6
Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine)
Published in Journal of medicinal chemistry (25-10-2018)“…MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse…”
Get full text
Journal Article -
7
Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor
Published in Bioorganic & medicinal chemistry letters (01-06-2017)“…[Display omitted] Hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent…”
Get full text
Journal Article -
8
Development and Scale-Up of a Manufacturing Route for the Non-nucleoside Reverse Transcriptase Inhibitor GSK2248761A (IDX-899): Synthesis of an Advanced Key Chiral Intermediate
Published in Organic process research & development (16-02-2018)“…A new and improved synthetic route to an intermediate in the synthesis of the phosphinate ester GSK2248761A is described. In the key step, we describe the…”
Get full text
Journal Article -
9
A highly diastereoselective chloride-mediated dynamic kinetic resolution at phosphorus on-route to a key intermediate in the synthesis of GSK2248761A
Published in Tetrahedron letters (30-05-2018)“…[Display omitted] •Stereoselective phosphinate esters synthesis.•Highest diastereoselectivity using a phenyl glycinamide derivative.•Isolated in 81% yield,…”
Get full text
Journal Article -
10
Novel methods for the synthesis of 1,5,2-diazaphosphinines as potential inhibitors of HCV polymerase
Published in Tetrahedron letters (18-01-2017)“…[Display omitted] •Two new methods for the preparation of the 1,5,2-diazaphosphinines are described.•The 1,5,2-diazaphosphinines are new HCV NS5B…”
Get full text
Journal Article -
11
Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor
Published in Journal of medicinal chemistry (10-03-2016)“…Here, we describe the design, synthesis, biological evaluation, and identification of a clinical candidate non-nucleoside reverse transcriptase inhibitors…”
Get full text
Journal Article -
12
Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase
Published in Journal of medicinal chemistry (03-05-2007)“…The Aurora kinases have been the subject of considerable interest as targets for the development of new anticancer agents. While evidence suggests inhibition…”
Get full text
Journal Article -
13
Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase
Published in Bioorganic & medicinal chemistry letters (15-09-2016)“…[Display omitted] The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional…”
Get full text
Journal Article -
14
Asymmetric hydrogenation reactions mediated by a new class of bicyclic bisphosphinites
Published in Tetrahedron: asymmetry (27-08-1999)“…The bicyclic alcohol (−)- 4 was prepared from (−)-bicyclo[3.2.0]hept-2-en-6-one (−)- 1 in 50% yield. The diol (−)- 4 was coupled to selected chlorophosphines…”
Get full text
Journal Article -
15
Synthesis of enantiopure 7-aminobicyclo[3.2.0]hept-2-en-6-ol; a potential N-O chelating ligand for enantioselective catalysis
Published in ARKIVOC (04-12-2000)Get full text
Journal Article Web Resource -
16
Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors
Published in Journal of medicinal chemistry (09-02-2006)“…The synthesis of a novel series of quinazolines substituted at C4 by five-membered ring aminoheterocycles is reported. Their in vitro structure−activity…”
Get full text
Journal Article